IL-13 and TNF-α inhibit dual-tropic HIV-1 in primary macrophages by reduction of surface expression of CD4, chemokine receptors CCR5, CXCR4 and post-entry viral gene expression

European Journal of Immunology

Volumn 30, Issue 5, 2000, Pages 1340-1349

  Bailer, Robert T ^a   Lee, Benhur ^b   Montaner, Luis J ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytokine; HIV 1; IL 13; Macrophage; TNF

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 13; LUCIFERASE; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ANTIBODY COMBINING SITE; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MURINE LEUKEMIA VIRUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS GENE; VIRUS REPLICATION;

ANTIGENS, CD4; CELLS, CULTURED; DRUG SYNERGISM; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HUMANS; INTERLEUKIN-13; MACROPHAGES; RECEPTORS, CCR5; RECEPTORS, CXCR4; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0034106952     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200005)30:5<1340::AID-IMMU1340>3.0.CO;2-L     Document Type: Article

References (43)

1. Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A. and Ho, D. D., Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993. 261: 1179-1181.
2. Orenstein, J. M., Fox, C. and Wahl, S. M., Macrophages as a source of HIV during opportunistic infections. Science 1997. 276: 1857-1861.
3. Montaner, L. J., Doyle, A. G., Collin, M., Herbein, G., Illei, P., James, W., Minty, A., Caput, D., Ferrara, P. and Gordon, S., Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J. Exp. Med. 1993. 178: 743-747.
4. Montaner, L. J., Griffin, P. and Gordon, S., Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. J. Gen. Virol. 1994. 75: 3393-3400.
5. Montaner, L. J., Bailer, R. T. and Gordon, S., IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production, and reduce virus infectivity. J. Leukoc. Biol. 1997. 62: 126-132.
6. Herbein, G., Montaner, L. J. and Gordon, S., Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor [published erratum appears in J. Virol. 1997. 71: 1581]. J. Virol. 1996. 70: 7388-7397.
7. Fauci, A. S., Host factors and the pathogenesis of HIV-induced disease. Nature 1996. 384: 529-534.
8. Pantaleo, G., How immune-based interventions can change HIV therapy [see comments]. Nat. Med. 1997. 3: 483-486.
9. Minty, A., Asselin, S., Bensussan, A., Shire, D., Vita, N., Vyakarnam, A., Wijdenes, J., Ferrara, P. and Caput, D., The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur. Cytokine Netw. 1997. 8: 203-213.
10. Jung, T., Wijdenes, J., Neumann, C., de Vries, J. E. and Yssel, H., Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and inteleukin-12. Eur. J. Immunol. 1996. 26: 571-577.
11. de Waal Malefyt, R., Abrams, J. S., Zurawski, S. M., Lecron, J. C., Mohan-Peterson, S., Sanjanwala, B., Bennett, B., Silver, J., de Vries, J. E. and Yssel, H., Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 cell clones and EBV-transformed B cells. Int. Immunol. 1995. 7: 1405-1416.
12. Hoshino, T., Winkler-Pickett, R. T., Mason, A. T., Ortaldo, J. R. and Young, H. A., IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J. Immunol. 1999. 162: 51-59.
13. Minty, A., Ferrara, P. and Caput, D., Interleukin-13 effects on activated monocytes leads to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma. Eur. Cytokine Netw. 1997. 8: 189-201.
14. de Waal Malefyt, R., Figdor, C. G., Huijbens, R., Mohan-Peterson, S., Bennett, B., Culpepper, J., Dang, W., Zurawski, G. and de Vries, J. E., Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 1993. 151: 6370-6381.
15. Vita, N., Lefort, S., Laurent, P., Caput, D. and Ferrara, P., Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J. Biol. Chem. 1995. 270: 3512-3517.
16. Bailer, R. T., Holloway, A., Sun, J., Margolick, J. B., Martin, M., Kostman, J. and Montaner, L. J., IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression. J. Immunol. 1999. 162: 7534-7542.
17. Goletti, D., Weissman, D., Jackson, R. W., Graham, N. M., Vlahov, D., Klein, R. S., Munsiff, S. S., Ortona, L., Cauda, R. and Fauci, A. S., Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J. Immunol. 1996. 157: 1271-1278.
18. Finnegan, A., Roebuck, K. A., Nakai, B. E., Gu, D. S., Rabbi, M. F., Song, S. and Landay, A. L., IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J. Immunol. 1996. 156: 841-851.
19. Weissman, D., Poli, G. and Fauci, A. S., IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J. Acquir. Immun. Defic. Syndr. Hum. Retrovirol. 1995. 9: 442-449.
20. Berger, E., Murphy, P. and Farber, J., Chemokine receptors as HIV-1 coreceptors: Role in vial entry, tropism, and disease. Annu. Rev. Immunol. 1999. 17: 657-700.
21. Lee, B. and Montaner, L. J., Chemokine immunobiology in HIV-1 pathogenesis. J. Leukoc. Biol. 1999. 65: 552-565.
22. Yi, Y., Rana, S., Turner, J. D., Gaddis, N. and Collman, R. G., CXCR-4 is expressed by primary macrophages and supports CCR5- independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J. Virol. 1998. 72: 772-777.
23. Denis, M. and Ghadirian, E., Interleukin 13 and interleukin 4 protect bronchoalveolar macrophages from productive infection with human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 1994. 10: 795-802.
24. Chang, J., Li, S., Naif, H. and Cunningham, A. L., The magnitude of HIV replication in monocytes and macrophages is influenced by environmental conditions, viral strain, and host cells. J. Leukoc. Biol. 1994. 56: 230-235.
25. Mangan, D. F., Welch, G. R. and Wahl, S. M., Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 1991. 146: 1541-1546.
26. Lee, B., Sharron, M., Montaner, L. J., Weissman, D. and Doms, R. W., Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 1999. 96: 5215-5220.
27. Connor, R. I., Chen, B. K., Choe, S. and Landau, N. R., Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995. 206: 935-944.
28. Chen, B. K., Saksela, K., Andino, R. and Baltimore, D., Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol. 1994. 68: 654-660.
29. Verani, A., Pesenti, E., Polo, S., Tresoldi, E., Scarlatti, G., Lusso, P., Siccardi, A. G. and Vercelli, D., CXCR4 is a functional coreceptor for infection of human macrophage by CXCR4-dependent primary HIV-1 isolates. J. Immunol. 1998. 161: 2084-2088.
30. Schmidtmayerova, H., Alfano, M., Nuovo, G. and Bukrinsky, M., Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol. 1998. 72: 4633-4642.
31. Simmons, G., Reeves, J. D., McKnight, A., Dejucq, N., Hibbitts, S., Power, C. A., Aarons, E., Schols, D., De Clercq, E., Proudfoot, A. E. and Clapham, P. R., CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J. Virol. 1998. 72: 8453-8457.
32. Manna, S. K. and Aggarwal, B. B., IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. J. Immunol. 1998. 161: 2863-2872.
33. Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H. and Fauci, A. S., Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 1989. 86: 2365-2368.
34. Wang, J., Roderiquez, G., Oravecz, T. and Norcross, M. A., Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J. Virol. 1998. 72: 7642-7647.
35. Chien, M. L., Foster, J. L., Douglas, J. L. and Garcia, J. V., The amphotropic murine leukemia virus receptor gene encodes a 71-kilodalton protein that is induced by phosphate depletion. J. Virol. 1997. 71: 4564-4570.
36. Kavanaugh, M. P., Miller, D. G., Zhang, W., Law, W., Kozak, S. L., Kabat, D. and Miller, A. D., Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA 1994. 91: 7071-7075.
37. Uckert, W., Willimsky, G., Pedersen, F. S., Blankenstein, T. and Pedersen, L., RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes. Hum. Gene Ther. 1998. 9: 2619-2627.
38. Herbein, G., Doyle, A. G., Montaner, L. J. and Gordon, S., Lipopolysaccharide (LPS) down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (TNF) and IL-1 beta. Clin. Exp. Immunol. 1995. 102: 430-437.
39. Lane, B. R., Markovitz, D. M., Woodford, N. L., Rochford, R., Strieter, R. M. and Coffey, M. J., TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J. Immunol. 1999. 163: 3653-3661.
40. Sica, A., Saccani, A., Borsatti, A., Power, C. A., Wells, T. N., Luini, W., Polentarutti, N., Sozzani, S. and Mantovani, A., Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 1997. 185: 969-974.
41. Sozzani, S., Ghezzi, S., Iannolo, G., Luini, W., Borsatti, A., Polentarutti, N., Sica, A., Locati, M., Mackay, C., Wells, T. N., Biswas, P., Vicenzi, E., Poli, G. and Mantovani, A., Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J. Exp. Med. 1998. 187: 439-444.
42. Collin, M. and Gordon, S., The kinetics of human immunodeficiency virus reverse transcription are slower in primary human macrophages than in a lymphoid cell line. Virology 1994. 200: 114-120.
43. Lenkei, R. and Andersson, B., Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors. J. Immunol. Methods 1995. 183: 267-277.